Recombinant Fusion Proteins [CS] - M0018640

Pharmacologic Code	M0018640
Pharmacologic Name	Recombinant Fusion Proteins
Pharmacologic Uses	bispecific CD19-directed CD3 T-cell engager CD25-directed cytotoxin CD2-directed LFA-3/Fc fusion protein selective T cell costimulation modulator
Pharmacologic Concept	Chemical Structure - [CS]
Pharmacologic Concept Description	This concept refers to the chemical structure and classification containing chemicals or other drug ingredients, organized into a chemical structure classification hierarchy.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Recombinant Fusion Proteins [CS].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0003-2187	Orencia	Non-Proprietary Name: Abatacept	Injection, Powder, Lyophilized, For Solution	Intravenous	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0003-2188	Orencia	Non-Proprietary Name: Abatacept	Injection, Solution	Subcutaneous	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0003-2814	Orencia	Non-Proprietary Name: Abatacept	Injection, Solution	Subcutaneous	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0003-2818	Orencia	Non-Proprietary Name: Abatacept	Injection, Solution	Subcutaneous	E.r. Squibb & Sons, L.l.c.	ACTIVE